The Default Mode Network: How Psilocybin Quiets Your Inner Static

In one sentence: The Default Mode Network (DMN) is the brain system that runs your internal narrator — replaying the past and rehearsing the future — and psilocybin temporarily turns its volume down.

The Default Mode Network is one of the most-studied brain systems in modern neuroscience and one of the most relevant to understanding why psychedelics affect mood, depression, and the sense of self. If you have ever wondered why you feel different on a microdose, the DMN is most of the answer.

This page explains what the network is, what it does, what goes wrong with it in depression and anxiety, and what the research actually shows about psilocybin’s effect on it.

What is the Default Mode Network in plain language?

The DMN is a set of brain regions that switch on when you are not focused on a task. When you stop reading, stop talking, stop solving — when you stare out the window — the DMN takes over.

It is the brain in idle mode. And idle does not mean off.

In idle, the DMN runs the part of your mental life that feels most like you: replaying yesterday’s argument, rehearsing tomorrow’s meeting, wondering what someone meant by that text, narrating your own story to yourself. Some neuroscientists call it the brain’s “internal narrator.” Others call it the “me network.”

The system was discovered almost by accident in the 1990s. Researchers running brain scans noticed certain regions stayed busy when subjects were supposedly resting. Marcus Raichle at Washington University formalized the finding in 2001, naming it the default mode of brain activity — the mode the brain falls into when nothing else demands attention.

What brain regions make up the DMN?

The Default Mode Network is not one structure. It is a coordinated set of regions that fire together. The core nodes are:

• Medial prefrontal cortex (mPFC) — self-referential thinking, “what does this mean about me?”
• Posterior cingulate cortex (PCC) — autobiographical memory and the sense of being a continuous person across time
• Precuneus — the felt sense of self, mental imagery, and perspective
• Angular gyrus (left and right) — connecting language, memory, and meaning
• Hippocampal formation — episodic memory retrieval

When these regions fire together in synchrony, you get the experience of being you — a single self, with a past, a future, and a story.

What does the Default Mode Network actually do?

Three things, mostly:

1. Self-referential thought. Anything that takes the form “what does this mean about me” runs through the DMN. Reading a comment online and thinking they didn’t reply, are they mad at me? is the DMN at work.
2. Mental time travel. Memory and prospection. Replaying the past, imagining the future. The DMN is what makes you able to mentally rehearse a conversation you have not had yet.
3. Theory of mind. Imagining what someone else is thinking. The DMN is heavily involved in social cognition and empathy.

In moderation, all three are useful. They are how humans plan, learn from mistakes, and maintain relationships. The problem starts when the DMN does not switch off.

What happens to the DMN in depression and anxiety?

In a healthy brain, the DMN turns up during rest and turns down during focused tasks. In a depressed brain, this on-off rhythm breaks. The DMN stays elevated even during tasks. Self-referential thinking — the me loop — runs constantly, regardless of whether the situation calls for it.

Researchers describe this as DMN hyperactivity, and it correlates with:

• Rumination — getting stuck on the same negative thought
• Self-criticism that does not respond to evidence
• A sense of being trapped inside one’s own story
• Difficulty being present
• Anhedonia — loss of pleasure in things you used to enjoy

A 2009 study by Sheline and colleagues at Washington University showed that people with major depressive disorder have measurably elevated DMN activity compared to healthy controls. Subsequent imaging research has replicated the finding many times.

The same pattern shows up in generalized anxiety, PTSD, and obsessive thinking, with slightly different regional emphasis.

How does psilocybin affect the Default Mode Network?

This is where the modern psychedelic research gets interesting.

In 2012, Robin Carhart-Harris and colleagues at Imperial College London ran the first fMRI study of psilocybin’s effect on the human brain. The results were the opposite of what most researchers expected. Psilocybin did not increase activity in any major brain network. It decreased activity in the Default Mode Network — sharply and consistently — and it loosened the synchronized firing between DMN nodes.

In other words, the part of the brain that runs your internal narrator went quiet, and the regions that normally talk to each other in lockstep started talking to other regions instead.

Subjects in the study reported what the researchers called “ego dissolution” — a temporary loss of the sharp boundary between me and not me. This experience correlated tightly with the degree of DMN suppression. The quieter the DMN went, the more the sense of self loosened.

A 2014 follow-up paper by the same team introduced the entropic brain hypothesis: the idea that psychedelics increase the variety of brain states by reducing the constraints the DMN normally enforces. Under psilocybin, the brain explores patterns it does not usually explore.

The effect lasts only a few hours during the acute experience. But here is the more interesting finding: in some studies, DMN activity remains slightly altered for days or weeks afterward. This is one mechanism researchers point to when they try to explain why a single psilocybin session can produce months of mood improvement.

Does microdosing affect the DMN the same way?

Probably not as dramatically. Microdoses are sub-perceptual by definition — you do not get the full ego dissolution experience, and the imaging signature is much subtler.

The honest answer is that very few studies have imaged the brains of microdosers under controlled conditions, and the ones that exist are small. What the research suggests so far is that microdosing produces a more modest version of the same effect: a slight reduction in DMN dominance, more flexibility in moving between thought patterns, and a quieter inner narrator.

The personal accounts line up. People who microdose for depression and anxiety often describe the experience the same way: the loops slow down, the inner critic becomes a voice instead of a fact, and there is more space between thoughts.

For the longer practical guide on this, see Microdosing Mushrooms for Anxiety and Depression.

What about meditation? Does that quiet the DMN too?

Yes — and the parallel is one of the most striking findings in modern neuroscience.

Long-term meditators show reduced DMN activity in resting-state imaging, similar in pattern (though not in magnitude) to what psilocybin produces acutely. Judson Brewer’s lab at Yale and later Brown University documented this in a series of studies starting around 2011. Experienced meditators showed less DMN activation during rest and reported less mind-wandering than controls.

This is part of why meditation and psychedelics keep getting compared in the research literature. They appear to act on overlapping circuitry by very different routes — one through years of disciplined attention, the other through a few hours of altered chemistry.

A 2019 study by Smigielski and colleagues combined the two: they gave psilocybin to meditators on a five-day silent retreat. The combination produced larger and longer-lasting changes than either intervention alone.

What we still do not know about the DMN

The science is real but the field is young. A few honest caveats:

• Most psilocybin imaging studies have small sample sizes (often under 30 people). The effects are consistent but the statistical power is modest.
• The DMN is correlated with rumination and depression, not proven to cause them. Some researchers argue overactive rumination causes DMN hyperactivity rather than the other way around.
• Microdosing-specific imaging studies are still rare. Most of what we know about psilocybin and the DMN comes from full-dose research.
• Long-term effects of repeated DMN suppression are not well understood. Most studies look at acute or short-term effects.
• Individual variation is large. Some people show big DMN changes on psilocybin and feel little subjective effect. Others show small DMN changes and feel transformed.

The consensus view, fairly summarized: psilocybin reduces DMN activity in a way that correlates with the subjective experience of ego loosening, and this is part — not all — of why psychedelics affect mood and depression.

Frequently Asked Questions

What is the Default Mode Network in simple terms?

The DMN is the brain system that runs your internal narrator — the voice that replays the past, rehearses the future, and tells you the story of who you are. It activates when you are not focused on a specific task.

Is the Default Mode Network bad?

No. In a healthy brain, the DMN is essential for memory, planning, and social understanding. The problem is when it stays elevated during tasks or runs constant negative self-referential loops, which is what happens in depression and rumination disorders.

Can you turn off your Default Mode Network?

Not entirely, and you would not want to. But you can reduce its dominance through focused attention (meditation, flow states, demanding tasks), through certain breathing practices, and pharmacologically through psychedelics like psilocybin.

Does psilocybin permanently change the Default Mode Network?

Acute effects last hours. Some studies suggest mild changes in DMN activity persist for days or weeks after a session. The evidence for permanent rewiring is limited and mostly comes from people who do repeated full-dose work over months.

Is the DMN the same as the ego?

Not exactly, but related. The DMN appears to be the neural substrate of self-referential thought, which is much of what people mean by “ego.” Reduced DMN activity correlates with the subjective experience of “ego dissolution” reported under psychedelics.

Sources and Further Reading

• Carhart-Harris, R. L., et al. (2012). “Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.” PNAS, 109(6), 2138–2143. Read paper
• Carhart-Harris, R. L., et al. (2014). “The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.” Frontiers in Human Neuroscience, 8, 20. Read paper
• Raichle, M. E. (2015). “The brain’s default mode network.” Annual Review of Neuroscience, 38, 433–447. Read paper
• Sheline, Y. I., et al. (2009). “The default mode network and self-referential processes in depression.” PNAS, 106(6), 1942–1947.
• Brewer, J. A., et al. (2011). “Meditation experience is associated with differences in default mode network activity and connectivity.” PNAS, 108(50), 20254–20259.
• Smigielski, L., et al. (2019). “Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat.” Scientific Reports, 9, 14914.

Related on The Microdose Movement

• Microdosing Mushrooms for Anxiety and Depression — the practical companion to this page
• Why You Feel Numb on Antidepressants — what SSRIs actually do to the same circuitry
• Psilocybin and Neuroplasticity — how short-term DMN suppression connects to lasting brain change
• The 5-HT2A Serotonin Receptor — the receptor that binds psilocin and starts the cascade

---

This page is for educational purposes. Nothing here is medical advice. The Microdose Movement is an educational community, not a clinical provider.